Glycobia

About:

Glycobia, Inc. develops platform technologies to enable glycoengineering, the intentional manipulation of protein-associated sugars to

Website: http://glycobia.com/

Description:

Glycobia, Inc. develops platform technologies to enable glycoengineering, the intentional manipulation of protein-associated sugars to alter inherent properties of proteins for research, industrial and therapeutic applications. The company engages in developing glyco-engineered bacteria that are capable of attaching human or human-like sugars onto proteins. The company provides technology for efficient production of authentic human glycoproteins in microbial cells for manufacturing and engineering of therapeutic proteins. Glycobia, Inc. was incorporated in 2008 and is based in Ithaca, New York.

Total Funding Amount:

$500000

Headquarters Location:

Ithaca, New York, United States

Founded Date:

2008-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2010-09-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai